MILabs BV has launched a complete new preclinical product line at the 2014 Annual European Association of Nuclear Medicine Meeting in Gothenburg, Sweden, October 18-22 (www.eanm.org). It consists of the new 4-series comprising U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT incorporating significant improvements over the former PLUS-series. The 4-series carries even further the tradition of MILabs to deliver the best SPECT and PET image resolution available in the market.
The new systems are more compact and include a dramatically improved X-Ray CT subsystem with reduced radiation dose, increased resolution and speed. The CT subsystem comes at three different resolution levels. The high resolution versions have significant added value for application areas such as. in vivo bone, cancer and arthritis research.
“Our customers are highly enthusiastic about the integrated low dose CT units and we are pleased to offer them dramatically improved resolution as well“, says Frederik Beekman, CEO/CSO of MILabs. This new generation U-SPECT4CT and VECTor4CT brings MILabs even further ahead in terms of combined ultra-high resolution functional and anatomical nuclear imaging. MILabs expects that the next generation U-SPECT4, U-SPECT4CT, VECTor4 and VECTor4CT systems will further accelerate the rapid growth of MILabs’ global customer base.
MILabs provides high-end preclinical imaging solutions for biomedical research. Today these systems contribute worldwide to the development of new diagnostic solutions and therapies for diseases such as diabetes, cancer, cardiac and neurodegenerative diseases. The systems are unique with U-SPECT as the highest resolution, fastest and highest sensitivity small-animal SPECT system and VECTor as the only technology capable of easily acquiring excellent simultaneous SPECT and PET imaging. These MILabs systems can be configured as fully integrated single, dual, or triple modal platform with choice of SPECT, PET and CT, with attractive options to smoothly combine these with Optical or MR imaging subsystems.
For more information please visit: www.milabs.com